NCT00002862View on ClinicalTrials.gov

Perillyl Alcohol in Treating Patients With Refractory Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 1996

Primary Completion Date

April 30, 2001

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

perillyl alcohol

Trial Locations (1)

06520-8028

Yale Comprehensive Cancer Center, New Haven

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002862 - Perillyl Alcohol in Treating Patients With Refractory Cancer | Biotech Hunter | Biotech Hunter